A Clinical trial to study the effects of two drugs, Chaturbhadra Kwath and Kutaj GhanaVati in patients with Vataja Grahani Roga (Irritable Bowel Syndrome).
Phase 3
- Conditions
- Health Condition 1: K582- Mixed irritable bowel syndrome
- Registration Number
- CTRI/2023/10/059227
- Lead Sponsor
- Dr Abdul Wahab
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients presenting with clinical features of Vataja Grahani Roga, IBS and fulfill the diagnostic criteria.
2. Patients between the age group of 20-70 years irrespective of sex, religion, occupation and socio-economic status.
3. Controlled non-communicable diseases and Controlled metabolic disorders.
Exclusion Criteria
1. Uncontrolled metabolic disorders and other systemic disorders
2. Patients presenting and previously diagnosed with Inflammatory bowel diseases, diverticulitis, Hemorrhoids, and peptic ulcer
3. Patients suffering from major diseases like CAD, Malignancy, Tuberculosis, STD, HIV
4. Patients who require surgical intervention for any such condition
5. Pregnancy and lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method